Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

429.60
-5.2200-1.20%
Pre-market: 430.550.9500+0.22%08:57 EDT
Volume:2.94M
Turnover:1.26B
Market Cap:110.32B
PE:-111.83
High:432.14
Open:430.17
Low:423.40
Close:434.82
Loading ...

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Zacks
·
28 Mar

Vertex, Inc. (NASDAQ:VERX) Has Found A Path To Profitability

Simply Wall St.
·
28 Mar

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead. -- Barrons.com

Dow Jones
·
27 Mar

IHI Corporation Transfers Shares of Construction Subsidiary to Vertex

TIPRANKS
·
27 Mar

Vortex Energy Corp. Announces Share Consolidation Effective April 1, 2025

TIPRANKS
·
27 Mar

Vertex Commerce Study: Returnuary’s Growing Complexity Forces Retailers to Keep Pace

GlobeNewswire
·
26 Mar

Microsoft Takes On Alphabet With This AI Advance. It's Copilot vs Gemini. -- Barrons.com

Dow Jones
·
26 Mar

Explorers Podcast: Vertex ready to claim its gold Reward

Stockheads
·
26 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Globus Medical (GMED) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
25 Mar

Vertex Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
25 Mar

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $512 From $500, Keeps Overweight Rating

MT Newswires Live
·
24 Mar

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Beacon Roofing, Liberty Energy

Reuters
·
24 Mar

Press Release: Vertex Resource Group Ltd. Reports Fourth Quarter and Year End 2024 Results

Dow Jones
·
24 Mar

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks
·
22 Mar

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
22 Mar

Vortex Energy Proposes Share Consolidation to Streamline Structure

TIPRANKS
·
21 Mar

Vertex Price Target Maintained With a $61.00/Share by Citizens Capital Markets

Dow Jones
·
20 Mar

Vertex Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
20 Mar

Vertex’s Ambitious Growth Targets and Uncertain Near-Term Prospects: A Hold Rating Analysis

TIPRANKS
·
20 Mar

Vertex Price Target Maintained With a $60.00/Share by Needham

Dow Jones
·
20 Mar